Case report: Fibrosing cholestatic hepatitis after living related-donor renal transplantation

Journal of Gastroenterology and Hepatology (Australia)

Volumn 13, Issue 11, 1998, Pages 1133-1137

  Waguri, Nobuo ^a   Ichida, Takafumi ^a   Fujimaki, Ryouko ^a   Ishikawa, Toru ^a   Nomoto, Minoru ^a   Asakura, Hitoshi ^a   Nakamaru, Tsukasa ^a   Saitoh, Akihiko ^a   Arakawa, Masaaki ^a   Saitoh, Kazuhide ^a   Takahashi, Kouta ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

Fibrosing cholestatic hepatitis; Hepatitis B virus; Living related donor renal transplantation; Precore mutant

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B ANTIGEN; IMMUNOSUPPRESSIVE AGENT;

ANIMAL CELL; ARTICLE; CASE REPORT; CHOLESTATIC HEPATITIS; CHRONIC KIDNEY FAILURE; HEPATITIS B; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; KIDNEY TRANSPLANTATION; LIVER FIBROSIS; MALE; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; VIRUS INFECTIVITY; VIRUS MUTATION; ADULT; CHOLESTASIS; ENZYME IMMUNOASSAY; FATALITY; FIBROSIS; IMMUNOLOGY; PATHOLOGY; POSTOPERATIVE COMPLICATION;

ADULT; CHOLESTASIS; FATAL OUTCOME; FIBROSIS; HEPATITIS B; HEPATITIS B ANTIGENS; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; POSTOPERATIVE COMPLICATIONS;

EID: 7844242547     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1998.tb00589.x     Document Type: Article

References (22)

1. Davies SE, Portmann BC, O'Grady JG et al. Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis. Hepatology 1991; 13: 150-7.
2. Todo S, Demetris AJ, Van Thiel DH, Taperman L, Fung JJ, Starzl TE. Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology 1991; 13: 619-26.
3. Lau JYN, Bain VG, Davies SE et al. High-level expression of hepatitis B viral antigen in fibrosing cholestatic hepatitis. Gastroenterology 1992; 102: 956-62.
4. Benner KG, Lee RG, Keeffe EB, Lopez RR, Sasaki AW, Pinson CW. Fibrosing cytolytic liver failure secondary to recurrent hepatitis B after liver transplantation. Gastroenterology 1992; 103: 1307-12.
5. Mason AL, Wick M, White HM et al. Increased hepatocyte expression of hepatitis B virus transcription in patients with features of fibrosing cholestatic hepatitis. Gastroenterology 1993; 105: 237-44.
6. Marcellin P, Giostra E, Peignoux MM et al. Redevelopment of hepatitis B surface antigen after renal transplantation. Gastroenterology 1991; 100: 1432-4.
7. Hamada T, Kumashiro R, Koga Y et al. Fatal acute hepatitis B virus infection while receiving immunosuppressants after renal transplantation. Intern. Med. 1993; 32: 547-51.
8. Chen CH, Chen PJ, Chu JS, Yeh KH, Lai MY, Chen DS. Fibrosing cholestatic hepatitis in a hepatitis B surface antigen carrier after renal transplantation. Gastroenterology 1994; 107: 1514-18.
9. Booth JCL, Goldin RD, Brown JL, Karayiannis P, Thomas HC. Fibrosing cholestatic hepatitis in a renal transplant recipient associated with the hepatitis B virus precore mutant. J. Hepatol. 1995; 22: 500-3.
10. Hung YB, Liang JT, Chu JS, Chen KM, Lee CS. Fulminant hepatic failure in a renal transplant recipient with positive hepatitis B surface antigens: a case report of fibrosing cholestatic hepatitis. Hepato-gastroenterology 1995; 42: 913-18.
11. Lam PWY, Wachs ME, Somberg KA, Vincenti F, Lake JR, Ferrell LD. Fibrosing cholestatic hepatitis in renal transplant recipients. Transplantation 1996; 61: 378-81.
12. Mclvor C, Morton J, Bryant A, Cooksley WG, Durrant S, Walker N. Fatal reactivation of precore mutant hepatitis B virus associated with fibrosing cholestatic hepatitis after bone marrow transplantation. Ann. Intern. Med. 1994; 121: 274-5.
13. Fang JWS, Wright TL, Lau JYN. Fibrosing cholestatic hepatitis in a patient with HIV and hepatitis B. Lancet 1993; 342: 1175 (letter).
14. Dusheiko G, Song E, Bowyer S et al. Natural history of hepatitis B virus infection in renal transplant recipients. A fifteen-year follow-up. Hepatology 1983; 3: 330-6.
15. Angus PW, Locarnini SA, McCaughan GW, Jones RM, McMillan JS, Bowden DS. Hepatitis B virus precore mutant infection is associated with severe recurrent disease after liver transplantation. Hepatology 1995; 21: 14-18.
16. Pirson Y, Alexandre GPJ, Strihou CY. Long-term effect of HBs antigenemia on patient survival after renal transplantation. N. Engl. J. Med. 1977; 296: 194-6.
17. Rao KV, Kasiske BL, Anderson WR. Variability in the morphological spectrum and clinical outcome of chronic liver disease in hepatitis B-positive and B-negative renal transplant recipients. Transplantation 1991; 51: 391-6.
18. Grotz W, Gondolf K, Rasenack J, Berthold H, Rump LC, Schollmeyer P. Imminent liver failure in a hepatitis-B-positive renal-allograft recipient: Successful therapy with interferon-α. Nephrol. Dial. Transplant. 1995; 10: 1932-4.
19. Hopf U, Neuhaus P, Lobeck H et al. Follow-up of recurrent hepatitis B and delta infection in liver allograft recipients after treatment with recombinant interferon-α. J. Hepatol 1991; 13: 339-46.
20. Feray C, Samuel D, Gigou M et al. An open trial of interferon alpha recombinant for hepatitis C after liver transplantation: Antiviral effects and risk of rejection. Hepatology 1995; 22: 1084-9.
21. Gish RG, Lau JYN, Brooks L et al. Ganciclovir treatment of hepatitis B virus infection in liver transplant recipients. Hepatology 1996; 23: 1-7.
22. Jamal H, Regenstein F, Farr G, Perrillo RP. Prolonged survival in fibrosing cholestatic hepatitis with long-term ganciclovir therapy. Am. J. Gastroenterol. 1996; 91: 1027-30.